U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07095842) titled 'Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)' on July 23.
Brief Summary: The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Convulsive Status EPILEPTICUS
Intervention:
DRUG: Ketamine
Intramuscular ketamine 2 mg/kg (max 90 mg)
DRUG: Midazolam
Intramuscular midazolam 0.2 mg/kg (max 10 mg)
Recruitment Status...